An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.569
https://www.valueinhealthjournal.com/article/S1098-3015(13)02474-1/fulltext
Title : An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02474-1&doi=10.1016/j.jval.2013.08.569
First page : A422
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 547
Categories :
Tags :
Regions :
ViH Article Tags :